MDS clinical diagnostic criteria for Parkinson’s disease

Postuma, Ronald B., Berg, Daniela, Stern, Matthew, Poewe, Werner, Olanow, C. Warren, Oertel, Wolfgang, Obeso, José, Marek, Kenneth +10 more·2015·Movement Disorders

DOI 10.1002/mds.26424

Cited by (1,019)

Items 401–500 of 1,019

Distinct patterns of amyloid‐dependent tau accumulation in Lewy body diseases
Seung Ha Lee, Hanna Cho, Jae Yong Choi, Jae‐Hoon Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo · 2017 · Movement Disorders
An early diagnosis is not the same as a timely diagnosis of Parkinson's disease
Richard Nathaniel Rees, Anita Acharya, Anette E. Schrag, Alastair John Noyce · 2018 · F1000Research
Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease
Andrea Guerra, Antonio Suppa, Valentina D’Onofrio, Flavio Di Stasio, Francesco Asci, Giovanni Fabbrini, Alfredo Berardelli · 2019 · Brain stimulation
Animal Model for Prodromal Parkinson’s Disease
Tomoyuki Taguchi, Masashi Ikuno, Hodaka Yamakado, Ryōsuke Takahashi · 2020 · International Journal of Molecular Sciences
Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
Marzena Kurzawa‐Akanbi, Seshu R. Tammireddy, Ivo Fabrik, Lina Gliaudelytė, Mary K. Doherty, Rachel E. Heap, Irena Matečko‐Burmann, Björn M. Burmann, Matthias Trost, John Milton Lucocq et al. · 2021 · Acta Neuropathologica
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
Anna Nicolaevna Bogolepova, Е Е Васенина, N. A. Gomzyakova, Evgeny I. Gusev, Nadezhda G. Dudchenko, А. Yu. Emelin, N. M. Zalutskaya, R. I. Isaev, Yu. V. Kotovskaya, Oleg Semenovich Levin et al. · 2021 · S S Korsakov Journal of Neurology and Psychiatry
Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment
Priyadarshi Prajjwal, Herson S Flores Sanga, Kirtish Acharya, Tamara Tango, Jobby John, Rene S.C. Rodriguez, Mohammed Dheyaa Marsool Marsool, Mukhamed Sulaimanov, Aneeqa Ahmed, Omniat Amir Hussin · 2023 · Annals of Medicine and Surgery
Exercise and gait/movement analyses in treatment and diagnosis of Parkinson’s Disease
Johannes Burtscher, Eduardo Martin Moraud, Davide Malatesta, Grégoire Paul Millet, Julien François Bally, Aurélien Patoz · 2023 · Ageing Research Reviews
Genetics in Parkinson’s disease, state-of-the-art and future perspectives
Lucia Trevisan, Andrea Gaudio, Edoardo Monfrini, Laura Avanzino, Alessio Di Fonzo, Paola Mandich · 2024 · British Medical Bulletin
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD
Dario Arnaldi, Silvia Daniela Morbelli, Andrea Brugnolo, Nicola Giovanni Girtler, Agnese Picco, Michela Ferrara, Jennifer Accardo, Ambra Buschiazzo, Fabrizio De Carli, Marco Pagani et al. · 2016 · Parkinsonism & Related Disorders
Clinical presentations of Wilson disease
Samuel Shribman, Thomas T. Warner, James S. Dooley · 2019 · Annals of Translational Medicine
ParkinSong: A Controlled Trial of Singing-Based Therapy for Parkinson’s Disease
Jeanette Tamplin, Meg E. Morris, Caterina Marigliani, Felicity Anne Baker, Adam P. Vogel · 2019 · Neurorehabilitation and neural repair
Differentially Expressed Circular <scp>RNAs</scp> in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease
Ravanidis, Stylianos, Bougea, Anastasia, Karampatsi, Dimitra, Papagiannakis, Nikolaos, Maniati, Matina, Stefanis, Leonidas, Doxakis, Epaminondas · 2021 · Movement Disorders
Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids
Niccolò Candelise, Simone Baiardi, Alessia Franceschini, Marcello Rossi, Piero Parchi · 2020 · Acta Neuropathologica Communications
Spatiotemporal features of β-γ phase-amplitude coupling in Parkinson’s disease derived from scalp EEG
Ruxue Gong, Mirko Wegscheider, Christoph Mühlberg, Richard Gast, Christopher Fricke, Jost‐Julian Rumpf, Vadim V. Nikulin, Thomas R. Knösche, Joseph Claßen · 2020 · Brain
Integrated Multi‐Cohort Analysis of the Parkinson's Disease Gut Metagenome
Joseph C. Boktor, Gil Sharon, Leo Verhagen Metman, Deborah A. Hall, Phillip A. Engen, Zoe J. Zreloff, Daniel Hakim, John W. Bostick, James A. Ousey, Danielle Lange et al. · 2023 · Movement Disorders
Redefining Non-Motor Symptoms in Parkinson’s Disease
Laura Peña-Zelayeta, Karen M. Delgado-Minjares, Marcos M. Villegas-Rojas, Karen León‐Arcia, Alberto Santiago-Balmaseda, Jesús Andrade-Guerrero, Isaac Pérez-Segura, Emmanuel Ortega‐Robles, Luis Oskar Soto-Rojas, Óscar Arias-Carrión · 2025 · Journal of Personalized Medicine
Deficits in olfactory sensitivity in a mouse model of Parkinson’s disease revealed by plethysmography of odor-evoked sniffing
Michaela Johnson, Liza Bergkvist, Gabriela Mercado, Lucas A. Stetzik, Lindsay K. Meyerdirk, Emily Wolfrum, Zachary Madaj, Patrik Brundin, Daniel W. Wesson · 2020 · Scientific Reports
Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease
Jannik Prasuhn, Michelle Prasuhn, Anja Fellbrich, Robert Strautz, Felicitas Lemmer, Shalida Dreischmeier, Meike Kasten, Thomas Frank Münte, Henrike Hanßen, Marcus Heldmann et al. · 2021 · Neurology
Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease
Zhuo Li, Gang Lü, Zhe Li, Bin Wu, Enli Luo, Xinmin Qiu, Jianwen Guo, Zhangyong Xia, Chunye Zheng, Qiaozhen Su et al. · 2021 · Frontiers in Immunology
Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson’s disease
Jan Rusz, Tereza Tykalová, Michal Novotný, Evžen Růžička, Petr Dušek · 2021 · npj Parkinson s Disease
Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories
Connor Bargar, Chiara Maria Giulia De Luca, Grazia Devigili, Antonio Emanuele Elia, Roberto Cilia, Sara Maria Portaleone, Wen Wang, Irene Tramacere, Edoardo Bistaffa, Federico Angelo Cazzaniga et al. · 2021 · Molecular Neurodegeneration
Parkinson disease-associated cognitive impairment
2021 · Nature Reviews Disease Primers
Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
Zhenhua Liu, Nannan Yang, Jie Dong, Wotu Tian, Lisa Chang, Jinghong Ma, Jifeng Guo, Jieqiong Tan, Ao Dong, Kaikai He et al. · 2022 · Nature Communications
Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management
Ryuji Sakakibara, Fuyuki Tateno, Tatsuya Yamamoto, Tomoyuki Uchiyama, Tomonori Yamanishi · 2017 · Clinical Autonomic Research
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
Martin T. Henrich, Fanni F. Geibl, Bolam Lee, Wei‐Hua Chiu, James B. Koprich, Jonathan M. Brotchie, Lars Timmermann, Niels Decher, Lina A. Matschke, Wolfgang Hermann Oertel · 2018 · Acta Neuropathologica Communications
The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development
Filippo Baldacci, Simone Lista, Giovanni Palermo, Filippo Sean Giorgi, Andrea Vergallo, Harald Juergen Hampel · 2019 · Expert Review of Proteomics
Hypomimia in Parkinson’s disease: an axial sign responsive to levodopa
Lucia Ricciardi, Andrea De Angelis, Luca Marsili, Irene Faiman, P. Pradhan, Erlick A C Pereira, Mark John Edwards, Francesca Morgante, Matteo Bologna · 2020 · European Journal of Neurology
Olfactory Dysfunction Predicts Disease Progression in Parkinson’s Disease: A Longitudinal Study
Runcheng He, Yuwen Zhao, Yan He, Yangjie Zhou, Jinxia Yang, Xiaoting Zhou, Liping Zhu, Xun Clare Zhou, Zhenhua Liu, Qian Xu et al. · 2020 · Frontiers in Neuroscience
An Update on Medical and Surgical Treatments of Parkinson’s Disease
Dipali Nemade, Thyagarajan Subramanian, Vikram Shivkumar · 2021 · Aging and Disease
Mitochondrial Function and Parkinson’s Disease: From the Perspective of the Electron Transport Chain
Jeng‐Lin Li, Tai-Yi Lin, Po‐Lin Chen, Ting-Ni Guo, Shu‐Yi Huang, Chun‐Hong Chen, Chin‐Hsien Lin, Chih‐Chiang Chan · 2021 · Frontiers in Molecular Neuroscience
Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease
Yumin Wang, Shuang Wu, Qiang Li, Weihong Lang, Wenjing Li, Xiaodong Jiang, Zhirong Wan, Jichao Chen, Hongquan Wang · 2022 · Frontiers in Pharmacology
Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's disease
Philipp Mahlknecht, Raimund Pechlaner, Sanne Boesveldt, Dieter Volc, Bernardette Pinter, Eva Reiter, Christoph Felix Müller, Florian Krismer, Henk W. Berendse, Jacobus Johannes van Hilten et al. · 2016 · Movement Disorders
Transcranial direct current stimulation enhances theory of mind in Parkinson’s disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study
Mauro Adenzato, Rosa Manenti, Ivan Enrici, Elena Gobbi, Michela Brambilla, Antonella Alberici, Maria Sofia Cotelli, Alessandro Padovani, Barbara Borroni, Maria Cotelli · 2019 · Translational Neurodegeneration
Alpha-Synuclein Nitration and Its Implications in Parkinson’s Disease
Yixi He, Zhongwang Yu, Shengdi Chen · 2018 · ACS Chemical Neuroscience
Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease
Fabian Maass, Sebastian Rikker, Vivian Dambeck, Carmina Carelia Warth Pérez Arias, Lars Tatenhorst, Ilona Csóti, Matthias Schmitz, Inga Zerr, Andreas Leha, Mathias Bähr et al. · 2020 · Scientific Reports
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson’s disease
Luca Magistrelli, Elisa Storelli, Emanuela Rasini, Elena Contaldi, Cristoforo Comi, Marco Cosentino, Franca Marino · 2020 · Brain Behavior and Immunity
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease
Cornelis Blauwendraat, Hirotaka Iwaki, Mary B. Makarious, Sara Bandrés‐Ciga, Hampton L. Leonard, Francis P. Grenn, Julie Lake, Lynne Krohn, Manuela M. X. Tan, Jonggeol Jeffrey Kim et al. · 2021 · Annals of Neurology
Combining skin and olfactory α-synuclein seed amplification assays (SAA)—towards biomarker-driven phenotyping in synucleinopathies
Anastasia Kuzkina, Jonas Rößle, A. Seger, Celine Panzer, A. Kohl, Virginia Maltese, Thomas Musacchio, Stefan Johannes Blaschke, Gültekin Tamgüney, Stefan Kaulitz et al. · 2023 · npj Parkinson s Disease
Parkinson’s Disease Biomarkers: Perspective from the NINDS Parkinson’s Disease Biomarkers Program
Katrina A. Gwinn, Karen Kate David, Christine Swanson‐Fischer, Roger L. Albin, Coryse St. Hillaire‐Clarke, Beth-Anne Sieber, Codrin Lungu, F. DuBois Bowman, Roy N. Alcalay, Debra Babcock et al. · 2017 · Biomarkers in Medicine
Photosensitive Melanopsin-Containing Retinal Ganglion Cells in Health and Disease: Implications for Circadian Rhythms
Pedro Lax, Isabel Ortuño‐Lizarán, Victoria Maneu, Manuel Vidal‐Sanz, Nicolás Cuenca · 2019 · International Journal of Molecular Sciences
Motor asymmetry over time in Parkinson’s disease
Cameron Miller‐Patterson, Richard Buesa, Nicole C R McLaughlin, Richard Norman Jones, Umer Akbar, Joseph H. Friedman · 2018 · Journal of the Neurological Sciences
Brain atrophy in Parkinson’s disease with polysomnography-confirmed REM sleep behavior disorder
Shady Rahayel, Malo Gaubert, Ronald B. Postuma, Jacques Yves Montplaisir, Julie Carrier, Oury Monchi, David Rémillard-Pelchat, Pierre-Alexandre Bourgouin, Michel Panisset, Sylvain Chouinard et al. · 2019 · SLEEP
Vision-Based Finger Tapping Test in Patients With Parkinson’s Disease via Spatial-Temporal 3D Hand Pose Estimation
Zhilin Guo, Weiqi Zeng, Taidong Yu, Yan Xu, Yang Xiao, Xuebing Cao, Zhiguo Cao · 2022 · IEEE Journal of Biomedical and Health Informatics
Parkinson's disease
Caroline H. Williams‐Gray, Paul F. Worth · 2016 · Medicine
The importance of preclinical diagnostics in Parkinson disease
Sneha Mantri, James F. Morley, Andrew D. Siderowf · 2018 · Parkinsonism & Related Disorders
Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patients
Ravanidis, Stylianos, Bougea, Anastasia, Papagiannakis, Nikolaos, Koros, Christos, Simitsi, Athina Maria, Pachi, Ioanna, Breza, Marianthi, Stefanis, Leonidas, Doxakis, Epaminondas · 2020 · Annals of Clinical and Translational Neurology
Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease
Huimin Chen, Huijuan Wan, Meimei Zhang, Genliang Liu, Xuemei Wang, Zhan Wang, Huizi Ma, Yuesong Pan, Tao Feng, Yilong Wang · 2021 · Parkinsonism & Related Disorders
Automated speech analysis in early untreated Parkinson's disease: Relation to gender and dopaminergic transporter imaging
Jan Rusz, Tereza Tykalová, Michal Novotný, David Zogala, Evžen Růžička, Petr Dušek · 2021 · European Journal of Neurology
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Matilde Bongianni, Mauro Catalan, Daniela Perra, Elena Fontana, Francesco Janes, Claudio Bertolotti, Luca Sacchetto, Stefano Capaldi, Matteo Tagliapietra, Paola Polverino et al. · 2022 · Translational Neurodegeneration
Transcutaneous auricular vagus nerve stimulation improves gait and cortical activity in Parkinson's disease: A pilot randomized study
Heng Zhang, Xingyue Cao, Lina Wang, Qing Tong, Huimin Sun, Caiting Gan, Aidi Shan, Yongsheng Yuan, Kezhong Zhang · 2023 · CNS Neuroscience & Therapeutics
Machine Learning-Based Classification of Parkinson’s Disease Patients Using Speech Biomarkers
Mohammad Amran Hossain, Francesco Amenta · 2023 · Journal of Parkinson s Disease
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks
K. A. Jellinger · 2023 · International Journal of Molecular Sciences
Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!
Joseph H. Friedman · 2017 · Parkinsonism & Related Disorders
Clinical, Dopaminergic, and Metabolic Correlations in Parkinson Disease
Fengtao Liu, Jingjie Ge, Jian-Jun Wu, Ping Wu, Yilong Ma, Chuantao Zuo, Jian Wang · 2018 · Clinical Nuclear Medicine
Predicting phenoconversion in pure autonomic failure
Elizabeth A. Coon, Jay N. Mandrekar, Sarah E. Berini, Eduardo E. Benarroch, Paola Sandroni, Phillip A. Low, Wolfgang Singer · 2020 · Neurology
Naringenin alleviates 6-hydroxydopamine induced Parkinsonism in SHSY5Y cells and zebrafish model
Swathi Kesh, Rajaretinam Rajesh Kannan, Anandan Balakrishnan · 2020 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
α-synuclein−lipoprotein interactions and elevated ApoE level in cerebrospinal fluid from Parkinson's disease patients
Wojciech Pasławski, Justyna Zarȩba-Pasławska, Xiaoqun Zhang, Katharina Hölzl, Henrik Wadensten, Mohammadreza Shariatgorji, Shorena Janelidze, Oskar Hansson, Lars Forsgren, Per E. Andrén et al. · 2019 · Proceedings of the National Academy of Sciences
Utility of Multi-Modal MRI for Differentiating of Parkinson's Disease and Progressive Supranuclear Palsy Using Machine Learning
Aron Sahand Talai, Jan Sedlacik, Kai Boelmans, Nils D. Forkert · 2021 · Frontiers in Neurology
A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson’s Disease for the Study of Non-Motor Symptoms
Débora Masini, Carina Plewnia, Maëlle Bertho, Nicolas Scalbert, Vittorio Caggiano, Gilberto Fisone · 2021 · Biomedicines
Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder
Hui Zhang, Álex Iranzo, Birgit Högl, Isabelle Arnulf, Luigi Ferini‐Strambi, Raffaele Manni, Tomoyuki Miyamoto, Wolfgang Hermann Oertel, Yves A Dauvilliers, Yo‐El S. Ju et al. · 2022 · Annals of Neurology
Early diagnosis of Parkinson's disease using Continuous Convolution Network: Handwriting recognition based on off-line hand drawing without template
Zhu Li, Jiayu Yang, Yanwen Wang, Miao Cai, Xiaoli Liu, Kang Lu · 2022 · Journal of Biomedical Informatics
Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson’s disease
Yun Fan, Yunpeng Sun, Wenbo Yu, Youqi Tao, Wencheng Xia, Yiqi Liu, Qinyue Zhao, Yilin Tang, Yi‐Min Sun, Fengtao Liu et al. · 2022 · Structure
Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
Laura Muñoz‐Delgado, Daniel Macías‐García, María Teresa Periñán, Silvia Jesús, Astrid Daniela Adarmes-Gómez, Marta Bonilla‐Toribio, Dolores Buiza‐Rueda, María Valle Jiménez‐Jaraba, Belén Benítez Zamora, Rafael Díaz Belloso et al. · 2023 · npj Parkinson s Disease
Update on the diagnosis and management of Parkinson's disease
Christopher Kobylecki · 2020 · Clinical Medicine
Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life
Khedr, Eman M., Abdelrahman, Ahmed A., Elserogy, Yasser, Zaki, Ahmed Fathi, Gamea, Ayman · 2020 · The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
Andrea Pilotto, Alberto Imarisio, Francesca Conforti, Andrea Scalvini, Stefano Masciocchi, Sara Nocivelli, Rosanna Turrone, Stefano Gipponi, Elisabetta Cottini, Barbara Borroni et al. · 2021 · Parkinsonism & Related Disorders
cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases
Kai Chen, Chuan Lai, Ying Su, Wen Dai Bao, Liu Nan Yang, Ping-Ping Xu, Ling-Qiang Zhu · 2021 · Current Neuropharmacology
Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: A pilot randomized, triple-blind, placebo-controlled trial
Hamidreza Ghodsi, Hamid Reza Rahimi, Seyedeh Mehrnaz Aghili, Amin Saberi, Ali Shoeibi · 2022 · Clinical Neurology and Neurosurgery
Clinical Aspects of the Differential Diagnosis of Parkinson’s Disease and Parkinsonism
Hae‐Won Shin, Sang-Wook Hong, Young Chul Youn · 2022 · Journal of Clinical Neurology
Glucocerebrosidase mutations and Parkinson disease
Sophia R.L. Vieira, Anthony H.V. Schapira · 2022 · Journal of Neural Transmission
Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease
Laura Muñoz‐Delgado, Miguel Ángel Labrador‐Espinosa, Daniel Macías‐García, Silvia Jesús, Belén Benítez Zamora, Paula Fernández‐Rodríguez, Astrid Daniela Adarmes-Gómez, María Isabel Reina Castillo, Sandra Castro‐Labrador, Jesús Silva‐Rodríguez et al. · 2023 · Movement Disorders
Biomarker-guided decision making in clinical drug development for neurodegenerative disorders
Jeffrey L. Cummings, Charlotte Elisabeth Teunissen, Brian K. Fiske, Isabelle Le Ber, Kristin R. Wildsmith, Michael Schöll, Billy Dunn, Philip Scheltens · 2025 · Nature Reviews Drug Discovery
The terminology of akinesia, bradykinesia and hypokinesia: Past, present and future
Johanna C.M. Schilder, Sandra S. Overmars, Johan Marinus, Jacobus Johannes van Hilten, Peter J. Koehler · 2017 · Parkinsonism & Related Disorders
LincRNA-p21 Inhibits Cell Viability and Promotes Cell Apoptosis in Parkinson’s Disease through Activating α -Synuclein Expression
Xiaonan Xu, Chengle Zhuang, Zimu Wu, Hongyan Qiu, Haixia Feng, Jun Wu · 2018 · BioMed Research International
Label-free detection of γ-aminobutyric acid based on silicon nanowire biosensor
Jin‐Ho Lee, Eun Ji Chae, Soo-jeong Park, Jeong‐Woo Choi · 2019 · Nano Convergence
Continuous Real-World Gait Monitoring in Idiopathic REM Sleep Behavior Disorder
Silvia Del Din, Alison Jane Yarnall, Thomas R. Barber, Christine Lo, M. James C. Crabbe, Michal Rolinski, Fahd Baig, Michele T. Hu, Lynn Rochester · 2019 · Journal of Parkinson s Disease
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease
Cristina Rascunà, Andrea Russo, Claudio Terravecchia, Niccolò Castellino, Teresio Avitabile, Vincenza Maria Elena Bonfiglio, Matteo Fallico, Clara Grazia Chisari, Calogero Edoardo Cicero, Marco Grillo et al. · 2020 · Frontiers in Neurology
The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease
T. Celeste Napier, Alana E. Kirby, Amanda L. Persons · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
Sonia Mayo, Julián Benito‐León, Carmen Peña‐Bautista, Miguel Baquero, Consuelo Cháfer‐Pericás · 2020 · Current Neuropharmacology
Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
Bruna Meira, Bertrand Degos, Elise Corsetti, Mohamed Doulazmi, Emeline Berthelot, Clara Virbel-Fleischman, Pauline Dodet, Aurélie Méneret, Louise‐Laure Mariani, Cécile Delorme et al. · 2021 · npj Parkinson s Disease
Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
Sanne K. Meles, Wolfgang Hermann Oertel, Klaus Leonhard Leenders · 2021 · Molecular Medicine
Platelet-to-lymphocyte ratio and neutrophil-tolymphocyte ratio may reflect differences in PD and MSA-P neuroinflammation patterns.
N. Madetko, B. Migda, Piotr Alster, Paweł Turski, D. Koziorowski, A. Friedman · 2022 · Neurologia i Neurochirurgia Polska
Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
Miriam Højholt Terkelsen, Ida Hyllen Klæstrup, Victor Schwartz Hvingelby, Johanne Lauritsen, Nicola Pavese, Marina Romero‐Ramos · 2022 · Journal of Parkinson s Disease
Autonomic Dysfunction in Early Parkinson's Disease: Results from the United Kingdom Tracking Parkinson's Study
Naveed Malek, Michael Lawton, Katherine A. Grosset, Nin P.S. Bajaj, Roger A. Barker, David John Burn, Thomas Foltynie, John Hardy, Huw R. Morris, Nigel M. Williams et al. · 2016 · Movement Disorders Clinical Practice
200 Years of Parkinson’s disease: what have we learnt from James Parkinson?
Claire McDonald, Gavin Gordon, Annette Hand, Richard William Walker, James Michael Fisher · 2017 · Age and Ageing
Pilot Study of the International Parkinson and Movement Disorder Society‐sponsored Non‐motor Rating Scale (MDS‐NMS)
Pablo Martínez‐Martín, Anette E. Schrag, Daniel A. Weintraub, Alexandra Rizos, Carmen Rodríguez‐Blázquez, К. Ray Chaudhuri, on behalf of the IPMDS Non Motor PD Study Group · 2019 · Movement Disorders Clinical Practice
Abnormal α‐synuclein deposits in skin nerves: intra‐ and inter‐laboratory reproducibility
Vincenzo Angelo Donadio, Kathrin Doppler, Alex Incensi, Anastasia Kuzkina, Annette Janzen, Geert Mayer, Jens Volkmann, Giovanni Rizzo, Elena Antelmi, Giuseppe Plazzi et al. · 2019 · European Journal of Neurology
Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder
Morten Gersel Stokholm, Álex Iranzo, Karen Østergaard, Mónica Serradell, Marit Otto, Kristina Bacher Svendsen, Alícia Garrido, Dolores Vilas, Tatyana Dmitrievna Fedorova, Joan Santamaría et al. · 2019 · European Journal of Neurology
Fine‐Mapping of SNCA in Rapid Eye Movement Sleep Behavior Disorder and Overt Synucleinopathies
Lynne Krohn, Richard Y. J. Wu, Karl Heilbron, Jennifer A. Ruskey, Sandra B. Laurent, Cornelis Blauwendraat, Armaghan Alam, Isabelle Arnulf, Michele T.M. Hu, Yves A Dauvilliers et al. · 2020 · Annals of Neurology
Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology
Sara R. Oliveira, Pedro A. Dionísio, Leonor Correia Guedes, Nilza Gonçalves, Miguel M Coelho, Mário Miguel Rosa, Joana D. Amaral, Joaquim José Ferreira, Cecília M. P. Rodrigues · 2020 · Biomolecules
Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samples
Jens O. Watzlawik, Xu Hou, Dominika Fričová, Chloe Ramnarine, Sandeep Kumar Barodia, Tania F. Gendron, Michael G. Heckman, Michael A. Deture, Joanna S. Siuda, Zbigniew K. Wszołek et al. · 2020 · Autophagy
Brain microglia activation and peripheral adaptive immunity in Parkinson’s disease: a multimodal PET study
Liu, Shu-Ying, Qiao, Hong-Wen, Song, Tian-Bin, Liu, Xiu-Lin, Yao, Yun-Xia, Zhao, Chun-Song, Barret, Olivier, Xu, Sheng-Li, Cai, Yan-Ning, Tamagnan, Gilles D. et al. · 2022 · Journal of Neuroinflammation
The Differential Diagnosis of Parkinson’s Disease
Julia C. Greenland, Roger A. Barker · 2018 · Codon Publications eBooks
Immunohistochemical Detection of Synuclein Pathology in Skin in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinsonism
Ahmed Al‐Qassabi, Tsu‐Shuen Tsao, Adriana Racolta, Thomas Kremer, Marta Cañamero, Anton Belousov, Madison A. Santana, Rachel C. Beck, Hongjun Zhang, Jeffrey A. Meridew et al. · 2020 · Movement Disorders
α‐Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives
Obada M. Alzghool, Guus A.M.S. van Dongen, Elsmarieke van de Giessen, Linda Jeanne Schoonmade, Wissam Beaino · 2022 · Movement Disorders
Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
Nour K. Majbour, Jan Olav Aasly, Ilham Y. Abdi, Simona S. Ghanem, Daniel Erskine, Wilma D. J. van de Berg, Omar M. A. El‐Agnaf · 2022 · Neurology
White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
Mahsa Dadar, Sawsan Mahmoud, Maryna Zhernovaia, Richard M. Camicioli, Josefina Maranzano, Simon Duchesne, For the CCNA Group · 2022 · NeuroImage Clinical
Serum inflammatory cytokines levels and the correlation analyses in Parkinson’s disease
Jiajia Fu, Sihui Chen, Jiao Liu, Jing Yang, Ruwei Ou, Lingyu Zhang, Xueping Chen, Huifang Shang · 2023 · Frontiers in Cell and Developmental Biology
Learning Hand Kinematics for Parkinson's Disease Assessment Using a Multimodal Sensor Glove
Yu Li, Junyi Yin, Chang Liu, Bing Xue, Cyrus Shokoohi, Gang Ge, Meng-Lei Monica Hu, Tenghuan Li, Xue Tao, Zhi Rao et al. · 2023 · Advanced Science